1 / 2

Pressure BioSciences Inc OTCMKTSPBIO Strong Consolidation May lead To Short Squeeze

Pressure BioSciences Inc (OTCMKTS:PBIO) is one of the more innovative companies around at this point in time and it could be a good idea for investors to have a bit of an idea about the company. It is involved in the manufacturing and sales of pressure-based products which could be used across several industries.

thestreetreports
Download Presentation

Pressure BioSciences Inc OTCMKTSPBIO Strong Consolidation May lead To Short Squeeze

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pressure BioSciences Inc (OTCMKTS:PBIO): Strong Consolidation May lead To Short Squeeze thestreetreports.com/pressure-biosciences-inc-otcmktspbio-strong-consolidation-may-lead-to-short-squeeze Pressure BioSciences Inc (OTCMKTS:PBIO) is one of the more innovative companies around at this point in time and it could be a good idea for investors to have a bit of an idea about the company. It is involved in the manufacturing and sales of pressure- based products which could be used across several industries. Market Stats On Thursday, PBIO stock moved up 2.58% to $1.59 with more than 7.9K shares, compared to its average volume of 14K shares. The stock moved within a range of $1.5350 – 1.6000 after opening trading at $1.53. The company has claimed that the products it manufactures have unique features since they deploy both alternating and constant hydrostatic pressure. In addition to that, the technology, PCT, which is used by Pressure BioSciences to manufacture these products, is also patented. That gives the company an added competitive advantage against its peers. At this point in time, the company is mainly focused on helping with industries like drug design, drug discovery, quality control, Biotherapeutics characterization, and forensics among others. However, the company has also claimed that many other 1/2

  2. opportunities are opening up as well, and eventually the pressure-based instruments could be in demand among a number of sectors. That is something that may well come as a source of optimism for investors and hence, it may well be a company worth tracking. There has not been a lot of news about the company in recent days but back on August 24, 2022 Pressure BioSciences had in fact made a major announcement. At the time the company announced that it had been successful in reaching an agreement to collaborate with Dr. Adrienne Dennis. DrDenese is the creator of the highly popular and successful skincare brand DrDenese Skincare. The brand is highly rated and has also won awards. A collaboration of that nature can only be as a positive for the long-term goals of Pressure BioSciences. The two companies are going to collaborate on specific skincare products as per the terms of the agreement between the two parties. Traders Corner PBIO stock is trading below the 20-Day and 50-Day Moving averages of $1.66 and $1.72. Moreover, the stock is trading below the 200-Day moving average of $1.92. 2/2

More Related